NEO-PREDEF(R) with TETRACAINE POWDER

Hazard statements (CLP)

H317, H334, H361d

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

OSHA Appearance White powder Classification of the Substance or Mixture GHS - Classification Respiratory Sensitization: Category 1 Skin Sensitization: Category 1 Reproductive Toxicity: Category 2

Signal word

Danger

Hazard statements

H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H317 - May cause an allergic skin reaction H361d - Suspected of damaging the unborn child May form combustible dust concentrations in air

Precautionary statements

P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P210 - Keep away from heat/sparks/open flames/hot surfaces. - No smoking P240 - Ground/Bond container and receiving equipment P280 - Wear protective gloves/protective clothing/eye protection/face protection P261 - Avoid breathing dust/fume/gas/mist/vapors/spray P285 - In case of inadequate ventilation wear respiratory protection P272 - Contaminated work clothing should not be allowed out of the workplace P308 + P313 - IF exposed or concerned: Get medical attention/advice P302+ P352 - IF ON SKIN: Wash with plenty of soap and water P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P362 - Take off contaminated clothing and wash before reuse P304 + P340 - IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations

Other hazards

Short Term Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Long Term Repeat-dose studies in animals have shown a potential to cause adverse effects on the developing fetus. Known Clinical Effects The most common adverse effects reported with clinical use were diarrhea, nausea, rash, and vomiting. Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. Clinical use of this drug has caused kidney dysfunction effects on hearing decrease in blood pressure (hypotension) nervousness blurred vision anxiety drowsiness convulsion respiratory arrest Drugs of this class may cause Cushing's syndrome, manifested by moon face, obesity, headache, acne, thirst, increased urination, impotence, menstrual irregularities, facial hair growth, and mental changes. Australian Hazard Classification (NOHSC): Note

Hazardous Ingredients

Non-Dangerous Goods This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

2.1 Classification of the substance or mixture

Respiratory Sensitization: Category 1 Skin Sensitization: Category 1 Reproductive Toxicity: Category 2 US OSHA Specific - Classification Physical Hazard: Combustible Dust EU Classification: EU Indication of danger: Not classified Label Elements